- Home
- IMNN vs CARV Comparison
IMNN vs CARV Comparison
Compare IMNN & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- CARV
- Stock Information
- Founded
- IMNN 1982
- CARV 1948
- Country
- IMNN United States
- CARV United States
- Employees
- IMNN N/A
- CARV N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- CARV Savings Institutions
- Sector
- IMNN Health Care
- CARV Finance
- Exchange
- IMNN Nasdaq
- CARV Nasdaq
- Market Cap
- IMNN 12.9M
- CARV 13.2M
- IPO Year
- IMNN 1985
- CARV 1994
- Fundamental
- Price
- IMNN $5.10
- CARV N/A
- Analyst Decision
- IMNN Buy
- CARV
- Analyst Count
- IMNN 2
- CARV 0
- Target Price
- IMNN $182.61
- CARV N/A
- AVG Volume (30 Days)
- IMNN 160.1K
- CARV 20.0K
- Earning Date
- IMNN 11-06-2025
- CARV 11-13-2025
- Dividend Yield
- IMNN N/A
- CARV N/A
- EPS Growth
- IMNN N/A
- CARV N/A
- EPS
- IMNN N/A
- CARV N/A
- Revenue
- IMNN N/A
- CARV $22,032,000.00
- Revenue This Year
- IMNN N/A
- CARV N/A
- Revenue Next Year
- IMNN N/A
- CARV N/A
- P/E Ratio
- IMNN N/A
- CARV N/A
- Revenue Growth
- IMNN N/A
- CARV N/A
- 52 Week Low
- IMNN $4.70
- CARV $1.30
- 52 Week High
- IMNN $41.22
- CARV $3.85
- Technical
- Relative Strength Index (RSI)
- IMNN 41.04
- CARV 61.49
- Support Level
- IMNN $4.91
- CARV $2.61
- Resistance Level
- IMNN $5.39
- CARV $2.79
- Average True Range (ATR)
- IMNN 0.24
- CARV 0.15
- MACD
- IMNN 0.00
- CARV -0.00
- Stochastic Oscillator
- IMNN 26.51
- CARV 85.98
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.